Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, the detection and prognosis of which are still unsatisfactory. Thus, it is essential to explore the factors that may identify ESCC and evaluate the prognosis of ESCC patients. RESULTS: Both protein...

Full description

Bibliographic Details
Main Authors: Chen, Z.-X (Author), Gan, T.-Q (Author), He, W.-Y (Author), Li, G.-S (Author), Li, J.-J (Author), Liu, H.-C (Author), Qin, G.-M (Author), Shen, L. (Author), Yang, L.-H (Author)
Format: Article
Language:English
Published: NLM (Medline) 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02819nam a2200481Ia 4500
001 10.3934-mbe.2021345
008 220427s2021 CNT 000 0 und d
020 |a 15510018 (ISSN) 
245 1 0 |a Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma 
260 0 |b NLM (Medline)  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3934/mbe.2021345 
520 3 |a BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, the detection and prognosis of which are still unsatisfactory. Thus, it is essential to explore the factors that may identify ESCC and evaluate the prognosis of ESCC patients. RESULTS: Both protein and mRNA expression levels of BIRC5 are upregulated in ESCC group rather than non-ESCC group (standardized mean difference > 0). BIRC5 mRNA expression is related to the age, tumor location, lymph node stage and clinical stage of ESCC patients (p < 0.05). BIRC5 expression makes it feasible to distinguish ESCC from non-ESCC (area under the curve > 0.9), and its high expression is related to poor prognosis of ESCC patients (restrictive survival time difference = -0.036, p < 0.05). BIRC5 may play an important role in ESCC by influencing the cell cycle pathway, and CDK1, MAD2L and CDC20 may be the hub genes of this pathway. The transcription factors-MAZ and TFPD1 -are likely to regulate the transcription of BIRC5, which may be one of the factors for the high expression of BIRC5 in ESCC. CONCLUSIONS: The current study shows that upregulation of BIRC5 may have essential clinical value in ESCC, and contributes to the understanding of the pathogenesis of ESCC. 
650 0 4 |a baculoviral IAP repeat containing protein 5 
650 0 4 |a baculoviral inhibitor of apoptosis repeat containing 5 
650 0 4 |a BIRC5 protein, human 
650 0 4 |a Carcinoma, Squamous Cell 
650 0 4 |a Esophageal Neoplasms 
650 0 4 |a esophageal squamous cell carcinoma 
650 0 4 |a Esophageal Squamous Cell Carcinoma 
650 0 4 |a esophagus tumor 
650 0 4 |a gene expression regulation 
650 0 4 |a Gene Expression Regulation, Neoplastic 
650 0 4 |a genetics 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a microarray 
650 0 4 |a prognosis 
650 0 4 |a RNA sequencing 
650 0 4 |a sophageal squamous cell carcinoma 
650 0 4 |a squamous cell carcinoma 
650 0 4 |a Survivin 
650 0 4 |a upregulation 
650 0 4 |a Up-Regulation 
700 1 |a Chen, Z.-X.  |e author 
700 1 |a Gan, T.-Q.  |e author 
700 1 |a He, W.-Y.  |e author 
700 1 |a Li, G.-S.  |e author 
700 1 |a Li, J.-J.  |e author 
700 1 |a Liu, H.-C.  |e author 
700 1 |a Qin, G.-M.  |e author 
700 1 |a Shen, L.  |e author 
700 1 |a Yang, L.-H.  |e author 
773 |t Mathematical biosciences and engineering : MBE